Medtronic Gross Margin 2010-2025 | MDT

Current and historical gross margin for Medtronic (MDT) over the last 10 years. The current gross profit margin for Medtronic as of January 31, 2025 is %.
Medtronic Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-01-31 $33.20B $21.67B 65.27%
2024-10-31 $33.00B $21.46B 65.04%
2024-07-31 $32.58B $21.23B 65.16%
2024-04-30 $32.36B $21.15B 65.34%
2024-01-31 $32.32B $21.17B 65.50%
2023-10-31 $31.96B $20.90B 65.40%
2023-07-31 $31.56B $20.73B 65.68%
2023-04-30 $31.23B $20.51B 65.67%
2023-01-31 $30.77B $20.44B 66.43%
2022-10-31 $30.81B $20.71B 67.21%
2022-07-31 $31.07B $21.01B 67.61%
2022-04-30 $31.69B $21.54B 67.98%
2022-01-31 $31.79B $21.58B 67.89%
2021-10-31 $31.80B $21.43B 67.39%
2021-07-31 $31.60B $21.02B 66.53%
2021-04-30 $30.12B $19.63B 65.19%
2021-01-31 $27.93B $17.83B 63.85%
2020-10-31 $27.87B $17.99B 64.57%
2020-07-31 $27.93B $18.36B 65.76%
2020-04-30 $28.91B $19.49B 67.41%
2020-01-31 $31.06B $21.42B 68.96%
2019-10-31 $30.89B $21.38B 69.22%
2019-07-31 $30.67B $21.35B 69.62%
2019-04-30 $30.56B $21.40B 70.04%
2019-01-31 $30.56B $21.49B 70.32%
2018-10-31 $30.38B $21.38B 70.38%
2018-07-31 $29.95B $21.03B 70.22%
2018-04-30 $29.95B $20.89B 69.73%
2018-01-31 $29.73B $20.62B 69.36%
2017-10-31 $29.64B $20.46B 69.02%
2017-07-31 $29.93B $20.55B 68.65%
2017-04-30 $29.71B $20.42B 68.72%
2017-01-31 $29.36B $20.14B 68.60%
2016-10-31 $29.01B $19.92B 68.66%
2016-07-31 $28.73B $19.78B 68.85%
2016-04-30 $28.83B $19.69B 68.29%
2016-01-31 $28.57B $18.86B 66.00%
2015-10-31 $25.95B $17.25B 66.48%
2015-07-31 $23.26B $15.60B 67.07%
2015-04-30 $20.26B $13.95B 68.86%
2015-01-31 $17.52B $12.98B 74.06%
2014-10-31 $17.37B $12.90B 74.27%
2014-07-31 $17.20B $12.78B 74.32%
2014-04-30 $17.01B $12.67B 74.52%
2014-01-31 $16.90B $12.60B 74.58%
2013-10-31 $16.76B $12.52B 74.68%
2013-07-31 $16.67B $12.49B 74.95%
2013-04-30 $16.59B $12.46B 75.13%
2013-01-31 $16.43B $12.39B 75.41%
2012-10-31 $16.32B $12.35B 75.66%
2012-07-31 $16.25B $12.34B 75.93%
2012-04-30 $16.18B $12.30B 75.97%
2012-01-31 $15.86B $12.11B 76.33%
2011-10-31 $15.80B $12.04B 76.22%
2011-07-31 $15.68B $11.92B 76.03%
2011-04-30 $15.51B $11.81B 76.14%
2011-01-31 $15.30B $11.73B 76.67%
2010-10-31 $15.30B $11.75B 76.81%
2010-07-31 $15.23B $11.72B 76.96%
2010-04-30 $15.39B $11.81B 76.73%
2010-01-31 $15.45B $11.72B 75.85%
2009-10-31 $15.09B $11.43B 75.70%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $105.938B $32.364B
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $227.162B 27.40
Boston Scientific (BSX) United States $140.689B 37.90
Stryker (SYK) United States $132.255B 28.42
EssilorLuxottica (ESLOY) France $128.431B 0.00
Lonza Group Ag (LZAGY) Switzerland $47.424B 0.00
Haleon (HLN) United Kingdom $46.151B 26.20
ResMed (RMD) United States $31.269B 24.08
Agilent Technologies (A) United States $29.217B 19.30
GE HealthCare Technologies (GEHC) United States $28.556B 13.89
Terumo (TRUMY) Japan $28.160B 0.00
Koninklijke Philips (PHG) Netherlands $22.192B 15.85
Zimmer Biomet Holdings (ZBH) United States $19.373B 12.24
Insulet (PODD) United States $17.332B 74.11
Baxter (BAX) United States $14.818B 10.66
Smith & Nephew SNATS (SNN) United Kingdom $11.356B 0.00
Sunny Optical Technology (SNPTF) China $7.609B 0.00
Lantheus Holdings (LNTH) United States $6.938B 17.06
Bio-Rad Laboratories (BIO) United States $6.672B 23.10
Demant (WILYY) Denmark $6.644B 0.00
Prestige Consumer Healthcare (PBH) United States $3.977B 18.98
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Perrigo (PRGO) Ireland $3.455B 9.89
ICU Medical (ICUI) United States $3.400B 29.07
Haemonetics (HAE) United States $2.872B 13.52
Envista Holdings (NVST) United States $2.614B 20.80
GN Store Nord (GNNDY) Denmark $2.188B 14.75
LeMaitre Vascular (LMAT) United States $1.946B 44.47
QuidelOrtho (QDEL) United States $1.698B 14.22
AtriCure (ATRC) United States $1.565B 0.00
Kestra Medical Technologies (KMTS) United States $1.214B 0.00
Green Thumb Industries (GTBIF) United States $1.189B 18.67
AdaptHealth (AHCO) United States $1.051B 10.12
BioLife Solutions (BLFS) United States $1.041B 0.00
InMode (INMD) Israel $1.038B 8.67
Neogen (NEOG) United States $0.953B 12.19
Phibro Animal Health (PAHC) United States $0.700B 10.74
Evolus (EOLS) United States $0.686B 0.00
Curaleaf Holdings (CURLF) Canada $0.649B 0.00
Valneva SE (VALN) France $0.552B 0.00
Owens & Minor (OMI) United States $0.535B 4.56
CeriBell (CBLL) United States $0.532B 0.00
Capricor Therapeutics (CAPR) United States $0.514B 0.00
Tilray Brands (TLRY) Canada $0.453B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.450B 0.00
Surmodics (SRDX) United States $0.394B 0.00
Omeros (OMER) United States $0.394B 0.00
SNDL (SNDL) Canada $0.368B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Cresco Labs (CRLBF) United States $0.328B 0.00
VAREX IMAGING (VREX) United States $0.302B 13.07
Viemed Healthcare (VMD) United States $0.262B 23.68
Sanara MedTech (SMTI) United States $0.262B 0.00
ZimVie (ZIMV) United States $0.261B 15.65
Sanuwave Health (SNWV) United States $0.256B 0.00
Verano Holdings (VRNOF) United States $0.251B 0.00
Aurora Cannabis (ACB) Canada $0.250B 44.40
Cerus (CERS) United States $0.242B 0.00
OraSure Technologies (OSUR) United States $0.224B 0.00
Quanterix (QTRX) United States $0.200B 0.00
Canopy Growth (CGC) Canada $0.189B 0.00
High Tide (HITI) Canada $0.187B 0.00
Biote (BTMD) United States $0.181B 4.12
TriSalus Life Sciences (TLSI) United States $0.175B 0.00
Utah Medical Products (UTMD) United States $0.172B 13.24
Brainsway (BWAY) Israel $0.155B 48.47
Jin Medical (ZJYL) China $0.147B 0.00
Organigram Global (OGI) Canada $0.135B 0.00
FitLife Brands (FTLF) United States $0.123B 15.42
Agape ATP (ATPC) $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Quipt Home Medical (QIPT) United States $0.086B 0.00
TerrAscend (TSNDF) Canada $0.083B 0.00
Exagen (XGN) United States $0.080B 0.00
MacroGenics (MGNX) United States $0.079B 0.00
Veru (VERU) United States $0.078B 0.00
Fonar (FONR) United States $0.076B 10.65
Zynex (ZYXI) United States $0.066B 24.22
United Health Products (UEEC) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.064B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
InterCure (INCR) Israel $0.063B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
United-Guardian (UG) United States $0.038B 11.61
Apyx Medical (APYX) United States $0.037B 0.00
Modular Medical (MODD) United States $0.036B 0.00
Rockwell Medical (RMTI) United States $0.035B 51.50
Safety Shot (SHOT) United States $0.033B 0.00
Nephros (NEPH) United States $0.021B 0.00
INLIF (INLF) $0.018B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
Flora Growth (FLGC) United States $0.010B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00